This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Coca-Cola Company (A): The Rise and Fall of M. Douglas Ivester (Abridged)
Watkins, Michael D.; Knoop, Carin-Isabel; Reavis, CateCase HBS-808074-EThis is a shortened version of The Coca-Cola Company (A): The Rise and Fall of M. Douglas Ivester, HBS case #9-800-355. It eliminates some background detail and the financial data and exhibits. As with the original case, it chronicles the appointment of Douglas Ivester as CEO of Coca-Cola and the missteps that led to his dismissal.Starting at €8.20
-
Novartis Pharma: Modelo de la Unidad de Negocio
Datar, Srikant M.; Knoop, Carin-Isabel; Reavis, CateCase HBS-110S30Accounting and ControlEn junio de 2000, Novartis reorganizó su negocio farmacéutico para formar unidades de negocio globales en oncología, trasplante, oftalmología, y madurar productos. Los productos de cuidado primario restantes continuaron siendo administrado dentro de las funciones globales (por ejemplo, I + D y comercialización). La nueva organización creó una estructura de matriz y las nuevas funciones y responsabilidades de los jefes de las funciones de negocio,...Starting at €8.20
-
Royal DSM: From Continuous Transformation to Organic Growth
George, William W.; Knoop, Carin-Isabel; Migdal, AmramCase HBS-317063-EStrategyRoyal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM's global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company's final moves away from commodity chemicals and toward more sustainable businesses whereby DSM could create value with differentiated offerings. Sijbesma emphasized innovation and mo...Starting at €8.20